Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2025-12-25 @ 5:08 AM
NCT ID:
NCT02732327
Eligibility Criteria:
Inclusion Criteria:
* Patients with neutropenic fever who have existing malignancy or have undergone hematopoietic stem cell transplantation
* Requires hospitalization for intravenous (IV) empiric antibiotic therapy
Exclusion Criteria:
* Fungal or viral infection requiring additional therapy
* Known acute viral hepatitis
* Known to be human immunodeficiency virus (HIV) positive
* Expected requirement for hemodialysis while on study therapy
* Received \>24 hours of systemic antibacterial therapy within 72 hours of initiation of inpatient IV study drug
* Past or current history of epilepsy or seizure disorder
* Evidence of immediately life-threatening disease, progressively fatal disease, or life expectancy of 3 months or less.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02732327
Study Brief:
Protocol Section:
NCT02732327